IPP Bureau
Polson Tie-up buys 10.01% stake in Natural Biogenex
By IPP Bureau - March 08, 2023
Natural Capsules Limited's shareholding will be reduced to 89.99%
93% companies lack the culture and organizational structure to unlock digital growth: Infosys
By IPP Bureau - March 08, 2023
Digital success is contingent on the way a company organizes itself around technology
Sun Pharma completes acquisition of Concert Pharmaceuticals
By IPP Bureau - March 07, 2023
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Alembic Pharmaceuticals gets USFDA final approval for fluorouracil injection
By IPP Bureau - March 07, 2023
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Venus Remedies joins India AMR Innovation Hub
By IPP Bureau - March 07, 2023
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
USFDA approves intramuscular administration for Merck’s MMRV family of vaccines
By IPP Bureau - March 07, 2023
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Apollo partners with LifeSigns to donate 1000 remote patient monitoring patches to Turkey
By IPP Bureau - March 07, 2023
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
Evonik partners with AMSilk to manufacture sustainable silk proteins
By IPP Bureau - March 07, 2023
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Aptar appoints Julie Xing to its Board of Directors
By IPP Bureau - March 07, 2023
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
Krsnaa Diagnostics completes Punjab Project
By IPP Bureau - March 06, 2023
The company operates 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory, and 95 Collection Centers
Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution
By IPP Bureau - March 06, 2023
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Aster DM Healthcare appoints Purana H Deepti as Additional Director
By IPP Bureau - March 06, 2023
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
Par Drugs and Chemicals receives WHO-GMP certificate
By IPP Bureau - March 06, 2023
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
By IPP Bureau - March 06, 2023
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments
By IPP Bureau - March 04, 2023
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
